The primary pathogen involved in certain forms of early-onset periodontitis is A. actinomycetemcomitans. Among its numerous potential virulence factors is a leukotoxin that kills certain host defense cells. In order to analyze the regulation and in vivo function of leukotoxin and other virulence factors in A. actinomycetemcomitans, molecular genetic approaches are being established. Although there has been significant progress in developing plasmids and bacteriophage as E. colilA. actinomycetemcomitans shuttle vectors, more work needs to be done. Tn5-based transposon mutagenesis has been shown to work in this organism. Targeted mutagenesis is now possible in A. actinomycetemcomitans; exogenously introduced DNA recombines efficiently with the homologous chromosomal locus. These techniques have been applied to studies of leukotoxin. Targeted mutagenesis has been used to construct leukotoxin negative mutants that are otherwise isogenic with their leukotoxin-producing parent strain. These mutants can be tested in animal models to ascertain the in vivo role of leukotoxin in A. actinomycetemcomitans pathogenesis. Gene targeting has also been used to make strains in which the leukotoxin promoter is regulating the synthesis of a β-galactosidase reporter gene. Such strains have been used to show that leukotoxin synthesis increases in cells grown anaerobically, but that several other environmental changes had little effect on leukotoxin synthesis. Finally, plasmid shuttle vectors with leukotoxin promoters from various strains of A. actinomycetemcomitans fused to reporter genes have been used in cis/trans tests to show that leukotoxin promoter sequences and strain-specific trans-acting factors are important in determining why different strains of A. actinomycetemcomitans produce different levels of leukotoxin. J Periodontol 1996;67:309-316.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1902/jop.1996.67.3s.309 | DOI Listing |
Sci Rep
December 2024
Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi state, MS, 39762, USA.
The production of lipopolysaccharide (LPS)-free recombinant proteins from culture supernatants is of great interest to biomedical research and industry. Due to the LPS-free cell wall structure and the well-defined secretion factor B (SecB)-dependent secretion pathway, Gram-positive bacteria are a superior alternative to Escherichia coli expression systems. However, the lack of inducible expression systems for high yields has been a bottleneck.
View Article and Find Full Text PDFMicrobiol Resour Announc
December 2024
Department of Microbiology & Molecular Genetics, The University of Texas Health Science Center, Houston, Texas, USA.
We report the complete genome sequence of a penicillin-resistant subsp. isolate, AJ79, from a tonsillitis patient. The AJ79 genome consists of a chromosome (2,440,359 bp) and plasmid (9,887 bp), providing insights into the genetic basis of penicillin resistance in and its implications for treating tonsillitis.
View Article and Find Full Text PDFInt J Mol Sci
November 2024
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality. Recent advancements in high-throughput omics techniques have enhanced our understanding of the human microbiome's role in the development of CVDs. Although the relationship between the gut microbiome and CVDs has attracted considerable research attention and has been rapidly evolving in recent years, the role of the oral microbiome remains less understood, with most prior studies focusing on periodontitis-related pathogens.
View Article and Find Full Text PDFmSphere
December 2024
Research Group for Global Capacity Building, National Food Institute, WHO Collaborating Centre (WHO CC) for Antimicrobial Resistance in Foodborne Pathogens and Genomics, FAO Reference Laboratory (FAO RL) for Antimicrobial Resistance, European Union Reference Laboratory for Antimicrobial Resistance (EURL-AR), Technical University of Denmark, Kongens Lyngby, Denmark.
EBioMedicine
November 2024
Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!